{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:25:32Z","timestamp":1762017932498},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5288","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T22:08:18Z","timestamp":1462054098000},"page":"1049-1054","source":"Crossref","is-referenced-by-count":5,"title":["Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease"],"prefix":"10.2169","volume":"55","author":[{"given":"Hisamitsu","family":"Miyaaki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naota","family":"Taura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Toriyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japanese Red-Cross Nagasaki Atomic Bomb Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep 4: 194-198, 2004.","DOI":"10.1007\/s11892-004-0023-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kaddai V, Negro F. Current understanding of insulin resistance in hepatitis C. Expert Rev Gastroenterol Hepatol 5: 503-516, 2011.","DOI":"10.1586\/egh.11.43"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lonardo A, Adinolfi LE, Restivo L, et al. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. World J Gastroenterol 20: 7089-7103, 2014.","DOI":"10.3748\/wjg.v20.i23.7089"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 60: 1394-1402, 2011.","DOI":"10.1136\/gut.2010.222844"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29: 198-206, 1998.","DOI":"10.1016\/S0168-8278(98)80004-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Uchida J, Iwai T, Machida Y, et al. Insulin resistance and insulin secretion in renal transplant recipients with hepatitis C. Transplant Proc 45: 1540-1543, 2013.","DOI":"10.1016\/j.transproceed.2013.01.053"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care 29: 1096-1101, 2006.","DOI":"10.2337\/dc05-2509"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R, Yki-Jarvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 293: E1709-E1715, 2007.","DOI":"10.1152\/ajpendo.00444.2007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J Clin Invest 78: 1648-1657, 1986.","DOI":"10.1172\/JCI112758"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135: 122-130, 2008.","DOI":"10.1053\/j.gastro.2008.03.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hennes MM, Dua A, Kissebah AH. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46: 57-62, 1997.","DOI":"10.2337\/diab.46.1.57"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Svedberg J, Bjorntorp P, Smith U, Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39: 570-574, 1990.","DOI":"10.2337\/diab.39.5.570"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rudovich NN, Rochlitz HJ, Pfeiffer AF. Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53: 2359-2365, 2004.","DOI":"10.2337\/diabetes.53.9.2359"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kashyap S, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461-2474, 2003.","DOI":"10.2337\/diabetes.52.10.2461"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bril F, Lomonaco R, Orsak B, et al. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology 59: 2178-2187, 2014.","DOI":"10.1002\/hep.26988"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474, 1999.","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ferrannini E, Balkau B, Coppack SW, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92: 2885-2892, 2007.","DOI":"10.1210\/jc.2007-0334"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Balkau B, Kahn HS, Courbon D, Eschwege E, Ducimetiere P. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: the Paris Prospective Study. Diabetes Care 24: 843-849, 2001.","DOI":"10.2337\/diacare.24.5.843"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miuma S, Ichikawa T, Taura N, et al. The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma. Oncol Rep 22: 1415-1424, 2009.","DOI":"10.3892\/or_00000583"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33: 106-115, 2000.","DOI":"10.1016\/S0168-8278(00)80166-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358-1364, 2001.","DOI":"10.1053\/jhep.2001.24432"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Taura N, Ichikawa T, Hamasaki K, et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol 101: 2752-2759, 2006.","DOI":"10.1111\/j.1572-0241.2006.00835.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.5288\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:21:52Z","timestamp":1498306912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.5288\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5288","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}